[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MY8700766A - Improvements in or relating to nasal pharmaceutical compositions - Google Patents

Improvements in or relating to nasal pharmaceutical compositions

Info

Publication number
MY8700766A
MY8700766A MY766/87A MY8700766A MY8700766A MY 8700766 A MY8700766 A MY 8700766A MY 766/87 A MY766/87 A MY 766/87A MY 8700766 A MY8700766 A MY 8700766A MY 8700766 A MY8700766 A MY 8700766A
Authority
MY
Malaysia
Prior art keywords
relating
pharmaceutical compositions
nasal pharmaceutical
nasal
compositions
Prior art date
Application number
MY766/87A
Other languages
English (en)
Inventor
Jean-Rene Keichel
Danielle Plas
Francoise A Cezat-Mispelter
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of MY8700766A publication Critical patent/MY8700766A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MY766/87A 1982-02-01 1987-12-30 Improvements in or relating to nasal pharmaceutical compositions MY8700766A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8202781 1982-02-01

Publications (1)

Publication Number Publication Date
MY8700766A true MY8700766A (en) 1987-12-31

Family

ID=10528017

Family Applications (1)

Application Number Title Priority Date Filing Date
MY766/87A MY8700766A (en) 1982-02-01 1987-12-30 Improvements in or relating to nasal pharmaceutical compositions

Country Status (27)

Country Link
JP (1) JPS58134017A (xx)
AT (1) AT385656B (xx)
AU (1) AU565613B2 (xx)
BE (1) BE895750A (xx)
CA (1) CA1197783A (xx)
CH (1) CH653555A5 (xx)
DE (1) DE3302949A1 (xx)
DK (1) DK164771C (xx)
ES (1) ES8502865A1 (xx)
FI (1) FI81258C (xx)
FR (1) FR2539994B1 (xx)
GR (1) GR81320B (xx)
HK (1) HK59989A (xx)
HU (1) HU191512B (xx)
IE (1) IE54532B1 (xx)
IL (1) IL67822A (xx)
IT (1) IT1197558B (xx)
KE (1) KE3888A (xx)
LU (1) LU84613A1 (xx)
MY (1) MY8700766A (xx)
NL (1) NL192325C (xx)
NZ (1) NZ203117A (xx)
PH (1) PH22198A (xx)
PT (1) PT76166B (xx)
SE (1) SE454402B (xx)
SG (1) SG34389G (xx)
ZA (1) ZA83673B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0715285D0 (en) * 2007-08-06 2007-09-12 Britannia Pharmaceuticals Ltd Improvements in or relating to powdered medicaments for nasal delivery
GB0910375D0 (en) * 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
US20190209463A1 (en) * 2018-01-05 2019-07-11 Impel Neuropharma, Inc. Intranasal delivery of dihydroergotamine by precision olfactory device

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
GB1202885A (en) * 1966-12-22 1970-08-19 Sandoz Ltd Pharmaceutical compositions comprising alkaloids
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
FR2387035A1 (fr) * 1977-04-12 1978-11-10 Cassenne Lab Sa Nouveau medicament destine notamment au traitement des troubles fonctionnels cerebraux
DE2831728C2 (de) * 1978-07-19 1982-12-23 Krewel-Werke Gmbh, 5208 Eitorf Arzneimittel zur Behandlung von Kopfschmerzen

Also Published As

Publication number Publication date
AT385656B (de) 1988-05-10
NZ203117A (en) 1986-12-05
HK59989A (en) 1989-08-04
NL192325B (nl) 1997-02-03
SG34389G (en) 1989-09-22
NL192325C (nl) 1997-06-04
JPH0253406B2 (xx) 1990-11-16
PH22198A (en) 1988-06-28
ES519450A0 (es) 1985-02-01
AU1085083A (en) 1983-08-11
DE3302949A1 (de) 1983-08-11
HU191512B (en) 1987-02-27
JPS58134017A (ja) 1983-08-10
SE8300495D0 (sv) 1983-01-31
CA1197783A (en) 1985-12-10
IL67822A0 (en) 1983-06-15
KE3888A (en) 1989-09-01
NL8300325A (nl) 1983-09-01
GR81320B (xx) 1984-12-11
FR2539994A1 (fr) 1984-08-03
LU84613A1 (fr) 1983-09-08
IE54532B1 (en) 1989-11-08
DK38183A (da) 1983-08-02
PT76166A (en) 1983-02-01
SE454402B (sv) 1988-05-02
FI830245A0 (fi) 1983-01-25
IT8347646A0 (it) 1983-02-01
BE895750A (fr) 1983-08-01
CH653555A5 (de) 1986-01-15
DK164771B (da) 1992-08-17
DK38183D0 (da) 1983-01-31
ATA30383A (de) 1987-10-15
FI81258B (fi) 1990-06-29
FI830245L (fi) 1983-08-02
IL67822A (en) 1988-02-29
DE3302949C2 (xx) 1992-05-21
SE8300495L (sv) 1983-08-02
ES8502865A1 (es) 1985-02-01
PT76166B (en) 1986-02-04
FR2539994B1 (fr) 1986-10-10
AU565613B2 (en) 1987-09-24
IE830187L (en) 1983-08-01
ZA83673B (en) 1984-09-26
FI81258C (fi) 1990-10-10
IT1197558B (it) 1988-12-06
DK164771C (da) 1992-12-28

Similar Documents

Publication Publication Date Title
GB2117703B (en) Improvements in or relating to fire-barriers
GB8326565D0 (en) Pharmaceutical compositions
HK16090A (en) Pharmaceutical compositions
GB8318564D0 (en) Pharmaceutical dermal compositions
IL70075A0 (en) Improvements in or relating to 3-aryl-5-pyrazole derivatives
ZA834074B (en) Pharmaceutical composition
EP0093551A3 (en) Pharmaceutical composition
GB2118176B (en) Pharmaceutical compositions
GB2117766B (en) Pharmaceutical compositions
GB8324133D0 (en) Pharmaceutical compositions
GB8429749D0 (en) Pharmaceutical compositions
CY1490A (en) Improvements in or relating to nasal pharmaceutical compositions
GB8313814D0 (en) Pharmaceutical compositions
GB8329700D0 (en) Anti-haemophilic pharmaceutical composition
DE3377696D1 (en) Pharmaceutical compositions
GB8328896D0 (en) Pharmaceutical composition
GB2134577B (en) Improvements in or relating to roadsigns
GB2118587B (en) Improvements in or relating to structures
MY8700766A (en) Improvements in or relating to nasal pharmaceutical compositions
GB8305028D0 (en) Pharmaceutical compositions
GB8332653D0 (en) Pharmaceutical composition
GB8314736D0 (en) Pharmaceutical compositions
GB8330810D0 (en) Pharmaceutical compositions
GB8331068D0 (en) Pharmaceutical compositions
IL68500A0 (en) Improvement in or relating to naphthalenamine derivatives